Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Levodopa Induced Dyskinesia”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Large-scale testing (Phase 3)Ended earlyNCT02153645
What this trial is testing

Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.

Who this might be right for
Parkinson's DiseaseLevodopa Induced Dyskinesias (LID)
Adamas Pharmaceuticals, Inc. 87
Testing effectiveness (Phase 2)Study completedNCT00888004
What this trial is testing

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients

Who this might be right for
Parkinson's DiseaseL-dopa Induced Dyskinesia
Novartis 28
Post-approval studies (Phase 4)Study completedNCT00307450
What this trial is testing

Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease

Who this might be right for
Parkinson's Disease
Technische Universität Dresden 34
Large-scale testing (Phase 3)Study completedNCT02202551
What this trial is testing

Open-Label Safety Study of ADS-5102 in PD Patients With LID

Who this might be right for
DyskinesiaLevodopa Induced Dyskinesia (LID)Parkinson's Disease (PD)
Adamas Pharmaceuticals, Inc. 223
Testing effectiveness (Phase 2)Study completedNCT01092065
What this trial is testing

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Who this might be right for
Parkinson's Disease
Novartis 23
Large-scale testing (Phase 3)Ended earlyNCT04857359
What this trial is testing

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 25
Testing effectiveness (Phase 2)Study completedNCT00160576
What this trial is testing

Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias

Who this might be right for
Idiopathic Parkinson Disease
UCB Pharma 30
Testing effectiveness (Phase 2)Ended earlyNCT00296959
What this trial is testing

Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University Health Network, Toronto 20
Not applicableLooking for participantsNCT06570824
What this trial is testing

RTMS as an Intervention for Levodopa-induced Dyskinesia

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Danish Research Centre for Magnetic Resonance 68
Testing effectiveness (Phase 2)Study completedNCT01491529
What this trial is testing

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+2 more
Novartis Pharmaceuticals 154
Testing effectiveness (Phase 2)Ended earlyNCT00607451
What this trial is testing

Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia

Who this might be right for
Levodopa-induced Dyskinesia
Neurim Pharmaceuticals Ltd. 8
Testing effectiveness (Phase 2)Study completedNCT00314288
What this trial is testing

Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

Who this might be right for
Parkinson's DiseaseDyskinesia
EMD Serono 360
Testing effectiveness (Phase 2)Study completedNCT03368170
What this trial is testing

Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia

Who this might be right for
Parkinson Disease
Integrative Research Laboratories AB 75
Testing effectiveness (Phase 2)Ended earlyNCT03922711
What this trial is testing

Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Prilenia 23
Large-scale testing (Phase 3)Study completedNCT02274766
What this trial is testing

Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia

Who this might be right for
DyskinesiaLevodopa-Induced Dyskinesia (LID)Parkinson's Disease (PD)
Adamas Pharmaceuticals, Inc. 77
Testing effectiveness (Phase 2)Temporarily pausedNCT04912115
What this trial is testing

Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia

Who this might be right for
DyskinesiasMovement DisordersCentral Nervous System Diseases+2 more
PharmaTher Inc. 30
Testing effectiveness (Phase 2)Study completedNCT02641054
What this trial is testing

Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease

Who this might be right for
Idiopathic Parkinson Disease
CleveXel Pharma 21
Testing effectiveness (Phase 2)WithdrawnNCT00758368
What this trial is testing

Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Oregon Health and Science University
Testing effectiveness (Phase 2)Study completedNCT00076674
What this trial is testing

Levetiracetam Treatment of L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 40
Large-scale testing (Phase 3)Study completedNCT02136914
What this trial is testing

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

Who this might be right for
DyskinesiaLevodopa Induced Dyskinesia (LID)Parkinson's Disease
Adamas Pharmaceuticals, Inc. 126
Next Page